See the difference! Customize Seeking Alpha:
Sign in or join
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
News, Data, Transcripts
Hollis-Eden Pharmaceuticals Inc. (HEPH)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: HEPH
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Biotech Day In Review: CuraGen Gets $155 Million For Gene Sequence Division
Centient Biotech Investor
•
Mar 30
•
1 Comment
Biotech In Review: Adams Respiratory Guides Lower
Centient Biotech Investor
•
Mar 18
•
Comment!
Hollis-Eden: BioDefense Drug Neumune's Failure Sickens Shareholders
10Q Detective
•
Mar 14
•
1 Comment
Biotech Day in Review: Hollis-Eden Loses Stockpile Contract for Neumune
Centient Biotech Investor
•
Mar 09
•
Comment!
Hollis-Eden: Government Contract Cancellation Could Mean Reorganization
Andrew Vaino
•
Mar 08
•
Comment!
Hollis-Eden: Stock Volatility Coming Up
Andrew Vaino
•
Mar 05
•
Comment!
More articles on HEPH »
Instablogs
Speculative BioTechs: Finding the Next 10-Bagger
Thu May 7, 2009
•
Joe Kunkle
•
6 Comments
Hollis Eden Pharmaceuticals-A Saga of Ego and Mismanagement
Wed April 8, 2009
•
Craig Miller/Metrobank's Views
•
Comment!
Write a post on HEPH
|
More Instablogs on HEPH »
Sentiment
What advice would you give to
HEPH?
123 characters left
What's your view of HEPH?
Make sure you include HEPH
140 characters left
|
Settings